Cargando…

Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?

BACKGROUND: Lipid accumulation product (LAP), a simple and low-cost tool, is a novel biomarker of central lipid accumulation and represents a potential surrogate marker for atherogenic lipoprotein profile. However, its association with lipoprotein subfractions has not been described in the literatur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cartolano, Flavia De Conti, Pappiani, Caroline, de Freitas, Maria Camila Prupper, Figueiredo Neto, Antonio M., Carioca, Antônio Augusto Ferreira, Damasceno, Nágila Raquel Teixeira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941956/ https://www.ncbi.nlm.nih.gov/pubmed/29791572 http://dx.doi.org/10.5935/abc.20180054

Ejemplares similares

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
por: Cartolano, Flávia De C., et al.
Publicado: (2017)

Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial
por: Cartolano, Flávia De Conti, et al.
Publicado: (2022)

Association of the conicity index with diabetes and hypertension in Brazilian women
por: Andrade, Mirelli Dantas, et al.
Publicado: (2016)

Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
por: de Freitas, Maria Camila Pruper, et al.
Publicado: (2018)

Green-banana biomass consumption by diabetic patients improves plasma low-density lipoprotein particle functionality
por: Lotfollahi, Zahra, et al.
Publicado: (2020)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
por: Krauss, Ronald M., et al.
Publicado: (2023)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
por: Chan, Sammy Y, et al.
Publicado: (2008)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Long-term fasting improves lipoprotein-associated atherogenic risk in humans
por: Grundler, Franziska, et al.
Publicado: (2021)

Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in adolescents: the healthy young cross-sectional study
por: da Silva, Isis T, et al.
Publicado: (2013)

Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
por: de Lima, Patricia Azevedo, et al.
Publicado: (2014)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions
por: Bagheri, Babak, et al.
Publicado: (2018)

The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins
por: Thierer, James H., et al.
Publicado: (2019)

Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients
por: Peela, Jagannadha R, et al.
Publicado: (2018)

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
por: Lotfollahi, Zahra, et al.
Publicado: (2022)

The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index
por: Çelik, Ersin, et al.
Publicado: (2021)

A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial
por: Burén, Jonas, et al.
Publicado: (2021)

Reply to Ravnskov, U. Is High Cholesterol Deleterious? An Alternative Point of View. Comment on “Burén et al. A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial. Nutrients 2021, 13, 814”
por: Burén, Jonas, et al.
Publicado: (2021)

Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
por: Schnitzler, Johan G., et al.
Publicado: (2020)

Omega-3 Fatty Acids in Erythrocyte Membranes as Predictors of Lower Cardiovascular Risk in Adults without Previous Cardiovascular Events
por: Gonçalinho, Gustavo Henrique Ferreira, et al.
Publicado: (2021)

Ácido Esteárico (mas não o Ácido Palmítico) está Associado a Biomarcadores Inflamatórios e de Disfunção Endotelial em Indivíduos em Risco Cardiovascular
por: Gonçalinho, Gustavo Henrique Ferreira, et al.
Publicado: (2023)

Os Ácidos Graxos Poli-insaturados Ômega-6 e Ômega-3 Presentes nas Hemácias Exercem uma Influência Distinta sobre o Tamanho das Partículas de LDL e suas Alterações Estruturais
por: Gonçalinho, Gustavo Henrique Ferreira, et al.
Publicado: (2023)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
por: Nagao, Manabu, et al.
Publicado: (2018)

Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
por: Dutheil, Frédéric, et al.
Publicado: (2014)

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile
por: Tom, Wynnis L., et al.
Publicado: (2016)

Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
por: Lin, Jennie, et al.
Publicado: (2015)

Author Correction: The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins
por: Thierer, James H., et al.
Publicado: (2020)

Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis
por: Pathak, Asmita, et al.
Publicado: (2020)

Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity
por: Farràs, Marta, et al.
Publicado: (2020)

Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein Subclasses
por: Stadler, Julia T., et al.
Publicado: (2022)

Mediating role of atherogenic lipoproteins in the relationship between liver fat and coronary artery calcification
por: Björnson, Elias, et al.
Publicado: (2023)

Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
por: Kim, Jae-Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ql79hs84opbf3ta08nucn96on0